Sirolimus-based graft-versus-host disease prophylaxis

被引：0
|
作者：
Ruggeri, Annalisa [1 ,2 ]
机构：
[1] Osped Pediat Bambino Gesu, IRCCS, Dept Pediat Hematol & Oncol, I-00165 Rome, Italy
[2] Hop St Louis, Eurocord, Paris, France
来源：
LANCET HAEMATOLOGY | 2019年 / 6卷 / 08期
关键词：
CELL TRANSPLANTATION; RAPAMYCIN; GVHD;
D O I：
10.1016/S2352-3026(19)30108-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E387 / E388
页数：2
相关论文
共 50 条
  • [21] Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors
    Peccatori, J.
    Forcina, A.
    Clerici, D.
    Crocchiolo, R.
    Vago, L.
    Stanghellini, M. T. L.
    Noviello, M.
    Messina, C.
    Crotta, A.
    Assanelli, A.
    Marktel, S.
    Olek, S.
    Mastaglio, S.
    Giglio, F.
    Crucitti, L.
    Lorusso, A.
    Guggiari, E.
    Lunghi, F.
    Carrabba, M.
    Tassara, M.
    Battaglia, M.
    Ferraro, A.
    Carbone, M. R.
    Oliveira, G.
    Roncarolo, M. G.
    Rossini, S.
    Bernardi, M.
    Corti, C.
    Marcatti, M.
    Patriarca, F.
    Zecca, M.
    Locatelli, F.
    Bordignon, C.
    Fleischhauer, K.
    Bondanza, A.
    Bonini, C.
    Ciceri, F.
    LEUKEMIA, 2015, 29 (02) : 396 - 405
  • [22] Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease
    Kumar, S
    Chen, MG
    Gastineau, DA
    Gertz, MA
    Inwards, DJ
    Lacy, MQ
    Tefferi, A
    Harmsen, WS
    Litzow, MR
    BONE MARROW TRANSPLANTATION, 2001, 27 (11) : 1133 - 1140
  • [23] Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease
    Ullmann, Andrew J.
    Lipton, Jeffrey H.
    Vesole, David H.
    Chandrasekar, Pranatharthi
    Langston, Amelia
    Tarantolo, Stefano R.
    Greinix, Hildegard
    Morais de Azevedo, Wellington
    Reddy, Vijay
    Boparai, Navdeep
    Pedicone, Lisa
    Patino, Hernando
    Durrant, Simon
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (04): : 335 - 347
  • [24] New advances in acute graft-versus-host disease prophylaxis
    Davies, JK
    Lowdell, MW
    TRANSFUSION MEDICINE, 2003, 13 (06) : 387 - 397
  • [25] Drug therapy for acute graft-versus-host disease prophylaxis
    Simpson, D
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (03): : 317 - 325
  • [26] PROPHYLAXIS AND TREATMENT OF GRAFT-VERSUS-HOST DISEASE (GVHD) WITH DRUGS
    DEEG, HJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 209 - 209
  • [27] Use of Belimumab for Prophylaxis of Chronic Graft-Versus-Host Disease
    Pusic, Iskra
    Johanns, Tanner
    Sarantopoulos, Stefanie
    Record, Haley
    Zeisset, Kaitlynn
    Westervelt, Peter
    Cashen, Amanda F.
    Uy, Geoffrey L.
    Abboud, Camille, Sr.
    DiPersio, John F.
    BLOOD, 2021, 138
  • [28] Rapamycine (Sirolimus) as salvage therapy for chronic graft-versus-host disease
    Jurado, M
    Vallejo, C
    Pérez-Simón, J
    Brunet, S
    Balsalobre, P
    Pérez-Oteyza, J
    Espigado, I
    Romero, A
    Caballero, D
    Díez, J
    Vázquez, L
    BONE MARROW TRANSPLANTATION, 2005, 35 : S139 - S139
  • [29] CYCLOSPORINE AND METHYLPREDNISOLONE FOR PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE
    SHEPHERD, JD
    SHORE, TB
    REECE, DE
    BARNETT, MJ
    KLINGEMANN, HG
    BUSKARD, NA
    PHILLIPS, GL
    BONE MARROW TRANSPLANTATION, 1988, 3 (06) : 553 - 558
  • [30] GRAFT-VERSUS-HOST DISEASE OR GRAFT-VERSUS-HOST LIKE SYNDROME
    BEYER, J
    SCHWERDTFEGER, R
    SIEGERT, W
    BLOOD, 1992, 80 (11) : 2948 - 2949
12345